2020
DOI: 10.1016/s2152-2650(20)30715-1
|View full text |Cite
|
Sign up to set email alerts
|

AML-117: The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles